What Do We Do With the Science of Monstrous Men?
By Daniel Engber,
Slate
| 07. 31. 2018
On May 18, W. French Anderson, known as the “father of gene therapy,” was released from prison on parole. Two weeks later, the 81-year-old scientist, pediatrician, and ex-con welcomed science writer Sharon Begley to his home in California for several days of interviews, which he gave with a GPS tracking device encircling his ankle. “This is what it has come to for a world-renowned scientist who was convicted of sexually molesting a colleague’s young daughter,” she writes at the top of her warm, weird, and at times outrageous profile for STAT last week.
There’s been a lot of talk, in recent months, about the legacies of monstrous men in the arts. We’ve reviewed the benefits and risks associated with their public shaming. We’ve re-appraised their prior work. We’ve wondered whether prodigious talents should be allowed to re-emerge and keep creating; and then we’ve theorized that our love of second chances enabled them from the start. Much less consideration has been given to the Monstrous Men in Science—the sundry research “pioneers” and “geniuses” who have turned out to be abusive bullies...
Related Articles
By Walt Bogdanich and Carson Kessler, The New York Times | 10.23.2024
By 2021, nearly 2,000 volunteers had answered the call to test an experimental Alzheimer’s drug known as BAN2401. For the drugmaker Eisai, the trial was a shot at a windfall — potentially billions of dollars — for defanging a disease...
By Deena Beasley, Reuters | 09.28.2024
Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with severe sickle cell pain earlier this month. She is doing what she can to prevent the crippling attacks in her arms...
By Ashleigh Wyss [cites CGS' Katie Hasson], Listnr | 10.09.2024
Discovering your genetic history can be as simple as spitting into a test tube, but what happens when your data ends up in the wrong hands?
With at-home DNA test kits becoming increasingly popular throughout the 2010s, curious consumers have...
By Tomoko Otake, The Japan Times | 10.17.2024
Screening embryos during in-vitro fertilization to select those with fewer genetic risks for common diseases and certain physical traits is technologically and ethically questionable, a group of researchers have said in a new study.
The Japan Society of Obstetrics and...